What We May Expect from Biomarkers in Heart Failure
- 1 October 2009
- journal article
- review article
- Published by Elsevier BV in Heart Failure Clinics
- Vol. 5 (4), 463-470
- https://doi.org/10.1016/j.hfc.2009.04.011
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Biomarkers in Heart FailureNew England Journal of Medicine, 2008
- Benchmarks for the Assessment of Novel Cardiovascular BiomarkersCirculation, 2007
- Endogenous urocortins reduce vascular tone and renin–aldosterone/endothelin activity in experimental heart failureEuropean Heart Journal, 2005
- The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in Val-HeFTEuropean Heart Journal, 2004
- B-Type Natriuretic Peptides and Ejection Fraction for Prognosis After Myocardial InfarctionCirculation, 2003
- Inflammatory Markers and Risk of Heart Failure in Elderly Subjects Without Prior Myocardial InfarctionCirculation, 2003
- Plasma Cytokine Parameters and Mortality in Patients With Chronic Heart FailureCirculation, 2000
- Beneficial Hemodynamic and Renal Effects of Adrenomedullin in an Ovine Model of Heart FailureCirculation, 1997
- Evidence for endothelin-1-mediated vasoconstriction in severe chronic heart failureThe Lancet, 1995
- Elevated Circulating Levels of Tumor Necrosis Factor in Severe Chronic Heart FailureNew England Journal of Medicine, 1990